Court-documented maltreatment was associated with small differences in GrimAge and DunedinPACE in sixth decade of life, but neither difference was statistically significant.
Patients with diabetes, hypertension, and current smoking in midlife lived nearly 13 fewer years without dementia than those with no vascular risk factors in a long-term US cohort study.
A systematic review and meta-analysis found small, consistent reductions in craving across substance use disorders, while evidence for withdrawal symptoms and substance dependence remained limited.
Female physicians ordered more testing and admitted a slightly higher share of patients, without differences in 30-day mortality or short inpatient stays.
Open‐label pilot trial found substantial symptom improvement and favorable safety findings in veterans receiving psilocybin-based therapy, supporting larger controlled studies.